Fibrinogen predicts mortality in high risk patients with peripheral artery disease

European Journal of Vascular and Endovascular Surgery

Volumn 26, Issue 4, 2003, Pages 381-386

  Doweik, L ^a   Maca, T ^a   Schillinger, M ^a   Budinsky, A ^a   Sabeti, S ^a   Minar, E ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Atherosclerosis; Fibrinogen; Mortality

Indexed keywords

FIBRINOGEN;

ADULT; AGED; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; FATALITY; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOMES RESEARCH; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

EID: 0142028037     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1078-5884(03)00340-X     Document Type: Article

References (22)

1. Lusis AJ. Atherosclerosis. Nature 2000; 407: 233-241.
2. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115-126.
3. Libby P, Ridker P, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
4. Glass CK, Witztum JL. Atherosclerosis: the road ahead. Cell 2001; 104: 503-516.
5. Mannucci PM. Recent progress in the pathophysiology of fibrinogen. Eur Heart J 1995; 16: 25-30.
6. Bombeli T, Schwartz BR, Harlan JM. Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3, integrin, and GPIbalpha. J Exp Med 1998; 187: 329-339.
7. Marguerie G, Ginsberg MH, Plow EF. In: Lane DA, Henschen A, Jasani MK, eds. Fibrinogen-fibrin formation and fibrinolysis. The Role of Fibrinogen in Platelet Aggregation, vol. 4. Berlin: Gruyter, 1986: 175-183.
8. Dejana E, Languino LR. In: Marvich R, ed. Blood vessel wall and thrombosis. Interaction of Platelets and Leukocytes with Endothelial Cells, vol. 1. Boca Raton, Florida: CRC, 1988: 197-206.
9. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 1993; 118: 956-963.
10. Lee AJ, Mowbray PI, Lowe GD et al. Blood viscosity and elevated intima-media thickness in men and women: the Edinburgh Artery Study. Circulation 1998; 97: 1467-1473.
11. Murabito JM, Evans JC, Nieto K et al. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J 2002; 143: 961-965.
12. Acevedo M, Pearce GL, Kottke-Marchant K et al. Elevated fibrinogen and homocysteine levels enhance the risk of mortality in patients from a high-risk preventive cardiology clinic. Arterioscler Thromb Vasc Biol 2002; 22: 1042-1045.
13. Whitton CM, Sands D, Hubbard AR et al. A ccolaborative study to establish the 2nd international standard for fibrinogen, plasma. Thromb Haemost 2000; 84: 258-262.
14. Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res 2001; 89: 763-771.
15. Elkind MS, Cheng J, Boden-Albala B, Paik MC, Sacco RL. Elevated white blood cell count and carotid plaque thickness: the northern Manhattan stroke study. Stroke 2001; 32: 842-849.
16. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyt count with coronary heart disease: meta analysis of prospective studies. JAMA 1998; 279: 1477-1482.
17. Ernst E. Fibrinogen. An independent risk factor for cardiovascular disease. BMJ 1991; 303: 596-597.
18. Maresca G, Di Blasio A, Marchioli R et al, Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update. Arterioscler Thromb Vasc Biol 1999; 19: 1368-1377.
19. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K et al. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501-505.
20. Folsom AR, Wu KK, Rosamond WD et al. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in the Communities (ARIC) Study. Circulation 1997; 96: 1102-1108.
21. Maison F, Mennen L, Sapinho D et al. A pharmacological assessment of the effect of statins and fibrates on fibrinogen concentration. Atherosclerosis 2002; 160: 155-160.
22. Bucher HC, Griffith LE, Guyatt GH. Systematic review on the risk and benefit of different cholesterol-lowering interventions. Arterioscler Thromb Vasc Biol 1999; 19: 187-195.